Agenda Released for SMi Group’s Adaptive Designs in Clinical Trials 2018
London, United Kingdom, November 25, 2017 --(PR.com)-- Now running for 10 years, SMi Group’s annual conference on Adaptive Designs in Clinical Trials returns to London in Spring 2018, gathering a senior audience of experts to discuss and deliberate recent innovations and successes in this exciting field of science.
Taking place on the 9th and 10th April, this year’s programme has been curated to provide delegates with the latest innovations, regulatory updates, and strategies on how industry and clinical experts are currently using adaptive designs in their clinical trials for successful drug, medical device and therapy development.
Putting a fresh spin on a methodological topic, the agenda will highlight how the pharmaceutical industry is currently riding the wave of technology. Experts will discuss how the increasing use of smartphone apps and digital devices is changing the way trials run. Simultaneously, the event will also explore how adaptive designs are being used for the production of personalised medicines and personalised therapies.
Other key highlights show case studies on enrichment designs and group sequential trials, as well as the latest regulatory perspectives from MHRA and EMA.
Featured experts presenting include:
James Matcham, Head of Biometrics, Early Clinical Development, AstraZeneca
Alex Sverdlov, Director, Statistical Scientist, Novartis
Frank Fleisher, Principal Methodology Statistician, Boehringer-Ingelheim
Christine Fletcher, Executive Director Biostatistics, Amgen
Chris Harbron, Principal Statistical Scientist, Roche
Daniela Casula, Lead Statistician, GlaxoSmithKline
Olivier Collignon, Biostatistician, European Medicines Agency
Beatrice Panico, Medical Advisor, MHRA
Corine Baayen, Senior Biostatistician, H.Lundbeck
Bob Clay, Managing Director, Highbury Regulatory Sciences
The full roster of speakers and their presentations can be accessed on www.adaptivedesigns.co.uk/prcom.
For those interested to attend, registration is now live on the event website and there is currently an Early Bird Discount of £400 which expires on 15 December 2017.
10th Adaptive Designs in Clinical Trials Conference
9-10 April 2018
Copthorne Tara Hotel, London, UK
For delegate registration enquiries, contact Kieran Ronaldson on kronaldson@smi-online.co.uk. For media enquiries, contact Honey de Gracia at hdegracia@smi-online.co.uk.
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Taking place on the 9th and 10th April, this year’s programme has been curated to provide delegates with the latest innovations, regulatory updates, and strategies on how industry and clinical experts are currently using adaptive designs in their clinical trials for successful drug, medical device and therapy development.
Putting a fresh spin on a methodological topic, the agenda will highlight how the pharmaceutical industry is currently riding the wave of technology. Experts will discuss how the increasing use of smartphone apps and digital devices is changing the way trials run. Simultaneously, the event will also explore how adaptive designs are being used for the production of personalised medicines and personalised therapies.
Other key highlights show case studies on enrichment designs and group sequential trials, as well as the latest regulatory perspectives from MHRA and EMA.
Featured experts presenting include:
James Matcham, Head of Biometrics, Early Clinical Development, AstraZeneca
Alex Sverdlov, Director, Statistical Scientist, Novartis
Frank Fleisher, Principal Methodology Statistician, Boehringer-Ingelheim
Christine Fletcher, Executive Director Biostatistics, Amgen
Chris Harbron, Principal Statistical Scientist, Roche
Daniela Casula, Lead Statistician, GlaxoSmithKline
Olivier Collignon, Biostatistician, European Medicines Agency
Beatrice Panico, Medical Advisor, MHRA
Corine Baayen, Senior Biostatistician, H.Lundbeck
Bob Clay, Managing Director, Highbury Regulatory Sciences
The full roster of speakers and their presentations can be accessed on www.adaptivedesigns.co.uk/prcom.
For those interested to attend, registration is now live on the event website and there is currently an Early Bird Discount of £400 which expires on 15 December 2017.
10th Adaptive Designs in Clinical Trials Conference
9-10 April 2018
Copthorne Tara Hotel, London, UK
For delegate registration enquiries, contact Kieran Ronaldson on kronaldson@smi-online.co.uk. For media enquiries, contact Honey de Gracia at hdegracia@smi-online.co.uk.
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact
SMi Group
Honey de Gracia
+44 (0) 20 7827 6102
http://www.adaptivedesigns.co.uk/prcom
Honey de Gracia
+44 (0) 20 7827 6102
http://www.adaptivedesigns.co.uk/prcom
Contact
Categories